Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat
- PMID: 8900311
- DOI: 10.1097/00007890-199610270-00015
Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat
Abstract
A study was conducted to determine the relationship among oral dose, trough whole blood levels, graft survival, and side effects in sirolimus-treated allografted rats. The heterotopic heart allograft model using Brown Norway donors and Lewis rat recipients was used. Rats were dosed daily with sirolimus or vehicle until graft failure or up to a maximum of 28 days. Upon graft failure, rats were bled for measurement of trough blood levels of drug and tissues sent for histopathologic analysis. Sirolimus blood concentration correlated positively with dose and graft survival. Significant graft survival occurred at whole blood trough levels of 0.5 ng/ml achieved at the 0.3 mg/kg/day dose. Analysis of the concentration-effect data using a sigmoidal Emax model calculated a whole blood EC50 of 2.0 ng/ml for graft survival. With mean trough concentrations of 7 ng/ml and higher, grafts survived after cessation of drug treatment. At the 0.8 mg/kg/day dose, there was a significant decrease in body weight gain in the rats. Histopathologic examination of sirolimus-treated animals detected thymic and lymphoid atrophy, both considered pharmacologic extensions of sirolimus's immunosuppressive activity and focal myocardial degeneration, an exacerbation of a spontaneous occurring lesion. These results demonstrate that sirolimus prolongs graft survival in rat in a concentration dependent manner with therapeutic whole blood levels of about 10 ng/ml.
Similar articles
-
The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.Transplantation. 1993 Feb;55(2):340-5. doi: 10.1097/00007890-199302000-00021. Transplantation. 1993. PMID: 8434385
-
Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.Transplantation. 1996 Feb 15;61(3):458-64. doi: 10.1097/00007890-199602150-00025. Transplantation. 1996. PMID: 8610361
-
Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.Transplant Proc. 1995 Feb;27(1):438-9. Transplant Proc. 1995. PMID: 7879053 No abstract available.
-
Pharmacokinetics of rapamycin.Transplant Proc. 1996 Apr;28(2):970-3. Transplant Proc. 1996. PMID: 8623483 Review.
-
Therapeutic monitoring of rapamycin: a new immunosuppressive drug.Ther Drug Monit. 1993 Dec;15(6):478-82. doi: 10.1097/00007691-199312000-00004. Ther Drug Monit. 1993. PMID: 8122280 Review.
Cited by
-
An approach to analyse the specific impact of rapamycin on mRNA-ribosome association.BMC Med Genomics. 2008 Aug 1;1:33. doi: 10.1186/1755-8794-1-33. BMC Med Genomics. 2008. PMID: 18673536 Free PMC article.
-
Microsphere-Based Rapamycin Delivery, Systemic Versus Local Administration in a Rat Model of Renal Ischemia/Reperfusion Injury.Pharm Res. 2015 Oct;32(10):3238-47. doi: 10.1007/s11095-015-1700-8. Epub 2015 May 9. Pharm Res. 2015. PMID: 25957099 Free PMC article.
-
Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation.Nitric Oxide. 2008 Feb;18(1):80-6. doi: 10.1016/j.niox.2007.10.001. Epub 2007 Oct 12. Nitric Oxide. 2008. PMID: 17971307 Free PMC article.
-
Rapamycin retards growth and causes marked alterations in the growth plate of young rats.Pediatr Nephrol. 2007 Jul;22(7):954-61. doi: 10.1007/s00467-007-0456-8. Epub 2007 Mar 17. Pediatr Nephrol. 2007. PMID: 17370095 Free PMC article.
-
A signal-on fluorosensor based on quench-release principle for sensitive detection of antibiotic rapamycin.Biosensors (Basel). 2015 Mar 26;5(2):131-40. doi: 10.3390/bios5020131. Biosensors (Basel). 2015. PMID: 25822756 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources